JPRN-UMIN000005227已完成未知
Transplantation of autologous and G-CSF mobilized mononuclear cells in patients with critical limb ischemia (CLI) - G-CSF mobilized MNC therapy in CLI patients
Regenerative Medicine Unit, Division of Vascular Regeneration Therapy, Institute of Biomedical Research and Innovation (IBRI)0 个研究点目标入组 5 人开始时间: 2011年3月9日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) CLI within category 6 on the Rutherford's scale 2) Less than 3 months since success of bypass surgery, transluminal angioplasty and sympathectomy for the limb expected to be transplanted 3) Left ventricular ejection fraction < 25% 4) Patients with a history of severe allergic reactions or side effects to G-CSF preparations or apheresis 5) Patients with malignant tumor 6) Patients with diabetic proliferating retinopathy (new Fukuda classification ii to BV) 7) Less than 3 months since last episode of unstable angina and myocardial/cerebral infarction 8) Patients with hematological disease (leukemia, myeloproliferative disease, myelodysplastic syndromes or sickle cell anemia) 9) Patients with collagen diseases 10) Patients with cirrhosis of the liver 11) Patients currently suffering from or having a history of interstitial pneumonitis 12) Patients with cerebral aneurysm judged to require treatment by a neurosurgeon 13) Leukocytes less than 4,000/micro L or exceeding 15,000/micro LL 14) Platelets less than 100,000/micro L 15) Hemoglobin less than 8 g/dL 16) AST(GOT) exceeding 100 IU/L or ALT (GPT) exceeding 100 IU/L 17) Patients for whom abdominal CT reveals splenomegaly 18) Patients with rest pain, ulcer or necrosis for reasons other than CLI (such as lumber spinal canal stenosis, arthropathy or vasculitis), 19) Patients who require major amputation regardless of whether revascularization is successful or not, because of exposure of the bone or tendon due to osteomyelitis, osteonecrosis, ulcer and soft tissue necrosis, or sepsis 20) Pregnant or nursing patients, those who may be pregnant, or those who plan on becoming pregnant before the end of the study period 21) Patients enrolled in any other clinical trial 22) Any other reason that the Clinical Supervisors or Clinical Researchers may have for considering a case unsuitable for the study.
研究者
相似试验
进行中（未招募）
1 期
CD34+ cell transplantation for patients with chronic kidney diseasechronic kidney diseaseJPRN-jRCTb030210237Ohtake Takayasu4
进行中（未招募）
3 期
A Phase III randomized, double-blinded, placebo-controlled trial to investigate the impact of intra-coronary transfusion of G-CSF mobilized autologous circulating hematopoietic stem/progenitor cells (CPC) therapy in patients with diffuse coronary artery disease who are not candidates for coronary artery interventioDiffuse Coronary Artery Disease (CAD) and non candidates for coronary artery interventionCirculatory SystemISRCTN14054375Chang Gung Memorial Hospital, Chang Gung Medical Foundation96
招募中
1 期
CD34+ cell transplantation for patients with acute renal failure.JPRN-jRCTb030190231OHTAKE Takayasu9
招募中
2 期
CD34+ cell transplantation for patients with spinal cord injuries.Spinal cord injuryJPRN-jRCTb030190220WATANABE Tsuyoshi6
招募中
2 期
CD34+ cell transplantation for patients with CLI.JPRN-jRCTb030190142OHTAKE Takayasu20